CoChat

CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau

Open access
Henjum, Kristi, Quist-Paulsen, Else, Zetterberg, Henrik, Blennow, Kaj, Nilsson, Lars N. G., Watne, Leiv Otto · 2018 · Journal of Neuroinflammation
Cited by 55

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Delirium and dementia share symptoms of cognitive dysfunctions, and mechanisms of neuroinflammation appear involved in both conditions. Triggering receptor expressed on myeloid cells 2 ( TREM2 ) is linked to dementia and neurodegenerative disease. It encodes expression of an innate immune receptor in the brain expressed by microglia. The level of the soluble fragment of TREM2 (sTREM2) is reported to increase in the cerebrospinal fluid (CSF) already in prodromal and asymptomatic Alzheimer’s disease. We analyzed the level of CSF sTREM2 in relation to delirium and dementia. The study included patients with or without pre-existing dementia who underwent acute hip fracture surgery ( n = 120), and some of the patients developed delirium ( n = 65). A medical delirium cohort ( n = 26) was also examined. ELISA was used to determine the level of sTREM2 in CSF. Delirium was associated with a higher level of CSF sTREM2 only among those without pre-existing dementia ( p = 0.046, n = 15, n = 44), particularly among patients developing delirium after CSF sampling ( p = 0.02, n = 7, n = 44). Between patients with dementia, there was no group difference, but the CSF sTREM2 level increased with waiting time for surgery ( r S = 0.39, p = 0.002, n = 60) and correlated well with the CSF Alzheimer’s disease biomarkers, Aβ42, and t-tau/p-tau ( r S = 0.40, p = 0.002, r S = 0.46, p < 0.001/ r S = 0.49, p < 0.001, n = 60). Among patients with dementia, the level of Aβ38 and Aβ40 also correlated positively with sTREM2 in CSF (Aβ38 MSD r S = 0.44, p = 0.001; Aβ40 MSD r S = 0.48, p < 0.001; Aβ42 MSD r S = 0.43, p < 0.001, n = 60). The findings reinforce the involvement of neuroinflammation in delirium, yet with separate responses in patients with or without pre-existing dementia. Our findings support the concept of primed microglia in neurodegenerative disease and central immune activation after a peripheral trauma in such patients. A CSF biomarker panel of neuroinflammation might be valuable to prevent delirium by identifying patients at risk.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12974-018-1331-1

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 55

Metadata

Authors
Henjum, K., Quist-Paulsen, E., Zetterberg, H., Blennow, K., Nilsson, L. N. G., & Watne, L. O.
Venue
Journal of Neuroinflammation
Published
2018-11-03
Volume
15
Issue
1
Pages
304-304
ISSN
1742-2094 (ISSN-L)
OpenAlex
W2899108000
Cited by
55
References
28
FWCI
3.03
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau. https://app.cochat.ai/papers/10.1186/s12974-018-1331-1
The paper
Henjum, K., Quist-Paulsen, E., Zetterberg, H., Blennow, K., Nilsson, L. N. G., & Watne, L. O. (2018). CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-018-1331-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.